Robert Nagourney's Colleagues at Nagourney Cancer Institute
Robert Nagourney's Contact Details
800-542-4357
Los Angeles,California,United States
Nagourney Cancer Institute
Robert Nagourney's Company Details
With 20+ years of research, Dr. Nagourney has developed the Ex Vivo Analysis of Programmed Cell Death (EVA-PCD) assay which is a state-of-the-art functional profiling test that produces a functional/phenotypic profile of a patient's cancer. This analysis is based on tumor biology and identifies in real-time which therapies amongst many comparable choices induce the cancer cells to shut down and die. This enables patients and their doctors to choose the most effective, least toxic treatment. Founded in 1995 by Dr. Robert Nagourney, Nagourney Cancer Institute (formerly Rational Therapeutics) is a fully accredited federal and state licensed laboratory with the main purpose of personalizing cancer patient's treatments. The EVA-PCD analysis has been shown to double response rates and increase survival. Nagourney Cancer Institute also provides services to pharmaceutical companies by determining efficacy of new drugs in a variety of human tumor diagnoses. Most types of cancers can be tested by Nagourney Cancer Institute and samples arrive from many parts of the world. Since the test involves living cancer cells, the samples must arrive in a very timely manner, within 24-36 hours. Contact our Patient Relations Representatives at 1-800-542-4357 to review your specific case. Nagourney Cancer Institute continues to be owned and operated by Dr. Nagourney and is the only cancer testing laboratory with an onsite practicing hematologist/oncologist. He is available for clinical consultations to help patients scientifically determine their best treatment options. Dr. Nagourney is a frequently invited speaker, an active blogger and author of the book Outliving Cancer. He has been featured on national and local television such as CNN, ABC World News Tonight, CNBC, Extra, Hard Copy, Fox 11 Los Angeles, KTLA 5 and major newspapers such as the Wall Street Journal and The Washington Times.#cancer #cancer research #cancer treatment